Table 2 Comparison between the non-HT patients and HI type 1 and 2 patients’ risk factors.

From: A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis

Risk factor, no, (percentage)

Non-HT group, N = 464

HI type 1, N = 73

P-value

HI type 2, N = 54

P-value

Hyperlipidemia

156.0 (33.6%)

24.0 (32.9%)

0.90

18.0 (33.3%)

0.13

Diabetes mellitus

164.0 (35.3%)

25.0 (34.2%)

0.86

20.0 (37.0%)

0.81

Hypertension

288.0 (62.1%)

47.0 (64.4%)

0.70

32.0 (59.3%)

0.69

Atrial fibrillation

67.0 (14.4%)

25.0 (34.2%)

< 0.001*

20.0 (37.0%)

< 0.001*

Ischemic heart disease

57.0 (12.3%)

7.0 (9.6%)

0.51

5.0 (9.3%)

0.52

Admission hyperglycemia

140.0 (30.2%)

25.0 (34.2%)

0.48

19.0 (35.2%)

0.45

Previous TIA

131.0 (28.2%)

19.0 (26.0%)

0.70

15.0 (27.8%)

0.94

Etiology, no, (percentage)

 Large artery atherosclerosis

68.0 (14.7%)

25.0 (34.2%)

< 0.001*

20.0 (37.0%)

< 0.001*

 Cardio-embolism

55.0 (11.9%)

36.0 (49.3%)

< 0.001*

28.0 (51.9%)

< 0.001*

 Small artery occlusion

152.0 (32.8%)

11.0 (15.1%)

0.002*

7.0 (13.0%)

0.003*

 Stroke of undetermined etiology

136.0 (29.3%)

26.0 (35.6%)

0.28

20.0 (37.0%)

0.24

Co-morbid conditions on admission

 Temperature on admission, median (IQR)

37.4 (37.2–37.8)

37.6 (37.3–37.9 )

0.41

37.6 (37.3–38.0)

0.36

 Cholesterol level on admission, mg/dL, median (IQR)

188.0 (181.0–237.0)

194.0 (187.0–246.0)

0.12

190.0 (189.0–245.0)

0.31

 Mean value of two points evaluation of BP within 24 h of symptoms onset, mmHg, median (IQR)

145.0 (130.0–165.0)

150.0 (135.0–165.0)

0.38

150.0 (135.0–165.0)

0.17

  1. HI hemorrhagic infarction, IQR inter-quartile range, p p value, *Statistically significant at p ≤ 0.05.